impak Ratings acquires Exerica
Paul Allard led and Société Générale Ventures and Altalurra Ventures backed impak Ratings acquired Exerica from founder Maxim Miller. Continue Reading
Paul Allard led and Société Générale Ventures and Altalurra Ventures backed impak Ratings acquired Exerica from founder Maxim Miller. Continue Reading
Avast plc paid US $325.9M for acquisition of SecureKey Technologies Inc. from Blue Sky Capital, Intel Capital, BMO, CIBC, RBC, ScotiaBank, TD, Desjardins, Visa, Mastercard, Discover, TELUS, and Rogers Venture Partners. Continue Reading
McCain Foods acquired Kruiningen, Netherlands based Scelta Products from founders Jos Koster and Wilco Boone. Scelta Mushrooms, cofounder of Scelta Products, will solely focus on its mushroom business going forward.Continue Reading
OMERS Infrastructure appointed Irini Kalamakis Senior Managing Director and Global Head of Strategic Partnerships. Kalamakis will join OMERS Infrastructure’s global Management Committee and report directly to Annesley Wallace, Global Head of Infrastructure. Continue Reading
David L. Sokol, Fairfax Financial Holdings Limited, the Washington Family, and Ocean Network Express Pte. Ltd. proposed to take Atlas Corp. (NYSE: ATCO) for US $4.1B or US $1.3B to minority shareholders. Continue Reading
OMERS Private Equity acquired Bionic Services Limited from ECI Partners and founders, Jeremy Elliott and Jonathan Elliott, with management team led by CEO Paul Galligan, ECI Partners and founders holding minority stakes.
Continue Reading
OMERS Private Equity entered into an agreement with Dan Holland and Stuart Fraser led management shareholders and Livingbridge to acquire Network Plus for undisclosed amount. Continue Reading
Acton Capital expanded team in Europe and presence in North America with Dr. Hannes Blum becoming new partner to head investments in Canada and US, and Dr. Sophie Ahrens-Gruber joining Munich investment team. Continue Reading
Triple Point Investment Management LLP managed Digital 9 Infrastructure plc (LSE: DGI9) to acquire 48.02% voting stake in Arqiva Group Limited from CPP Investments for £300 million or CDN $585 million. Continue Reading
Accenture plc (NYSE: ACN) entered into an agreement to acquire XtremeEDA from founder Claude Cloutier and other shareholders. Continue Reading
Johnny Warström and Niklas Ingvar founded Mentimeter AB secured US $42M Series C funding led by Creades, Nordstjernan Growth, and Alfvén Didrikson. Continue Reading
Domain Therapeutics SA secured €39M Series A co-led by Panacea Venture, CTI Life Sciences and 3B Future Health Fund, with participation of adMare BioInnovations, Schroder Adveq, Omnes Capital, Turenne Capital, Theodorus, Viva BioInnovator, Seventure Partners. Continue Reading
Neil Potts and Rachel Hugh founded and Dismatrix backed The Vurger Co Ltd. closed a Canadian private placement by way of convertible debenture financing and will likely seek Canadian public listing. Continue Reading
Claude Perreault and Pierre Thibault founded Epitopea secured £10.3 seed funding from CTI Life Sciences, Advent Life Sciences, Cambridge Innovation Capital (CIC), Fonds de solidarité FTQ, Novateur Ventures, Harrington Discovery Institute/University Health Holdings. Continue Reading
Cycle Capital and Demeter held 1st close for €150M Circular Innovation Fund (CIF) with commitments from L’Oréal (€50M), Claridge Inc., Axens, Haltra, private investors, and managers. CIF will be led by Benoit Forcier and Mathieu Goudot, with support of Adeline Kempf and Maya Hassa. Continue Reading
Eric Martineau-Fortin, Jean-François Marcoux and Sep Alavi led WSC (White Star Capital) Digital Assets II Limited Partnership held US $60M initial close with anchor commitment from Ubisoft. Continue Reading
Fairfax Financial Holdings Limited to acquire additional 25M shares of Atlas Corp. through warrant exercises, increasing beneficial ownership from 39.6% to 45.1% of issued and outstanding common shares of Atlas. Continue Reading
© 2023 CPE News, a division of CPE Media & Data Company. All Rights Reserved. 500-245 Fairview Mall Drive, Toronto, Ontario M2J 4T1 | 647-872-6300